Skip to main content

Table 1.

Patient Characteristics at Randomization

Characteristic Vitamin D3 (n = 47) Placebo (n = 48)
Demographic
 Age, y 56.0 (39.5-65.0) 46.0 (37.5-63.5)
 Female sex 21 (44.7) 25 (52.1)
 Race/ethnicity
 Black 4 (8.5) 8 (16.7)
 Hispanic 5 (10.5) 5 (10.4)
 Facility residence before hospitalization
 Home
 Independent 39 (83.0) 39 (81.2)
 With help) 5 (10.6) 7 (14.6)
 With professional help 2 (4.3) 0 (0.0)
 Skilled nursing facility 1 (2.1) 2 (4.2)
 Dementia 5 (10.6) 4 (8.3)
 Education, y 14 (12-16) 14 (12-16)
 Barona Index 108 (102-113) 109 (102-113)
Clinical
 Charlson Comorbidity Index 3.00 (1.00-4.50) 2.00 (0.00-3.75)
 BMI, kg/m2 30.9 (25.3-34.0) 30.7 (27.6-34.5)
 Lung injury risk factors
 Pneumonia 19 (40.4) 15 (31.2)
 Sepsis 21 (44.7) 17 (35.4)
 Shock 18 (38.3) 16 (33.3)
 Mechanical ventilation for acute respiratory failure 3 (6.4) 8 (16.7)
 Aspiration 0 (0.0) 2 (4.2)
 Lung contusion 4 (8.5) 3 (6.2)
 Pancreatitis 0 (0.0) 2 (4.2)
 Smoke inhalation 0 (0.0) 0 (0.0)
 Infection (sepsis or pneumonia diagnosis) 30 (63.8) 30 (62.5)
 Illness severity
 SOFA score 4.00 (2.00-7.00) 5.00 (2.00-7.00)
 LIPS 5.50 (3.00-7.50) 5.00 (3.25-7.00)
 Mechanical ventilation 7 (14.9) 9 (18.8)
 Vasopressor use 11 (23.4) 14 (29.2)
 Vital signs
 Pulse rate, beats/min 83 (75.5-98.0) 95.5 (86-114)
 BP, mm Hg
 Systolic 113 (102.5-129) 112 (104-134)
 Diastolic 65 (52-75) 66 (57-79)
 Respiratory rate, per min 20 (18-24.5) 19 (16-25)
 Oxygen saturation, % 97 (94-98) 97 (94-98)
Vitamin D related
 25-hydroxyvitamin D, ng/mL 15.2 (12.9-17.4) 13.1 (12.9-15.9)
 eGFR, mL/min/1.73 m2 43.0 (32.9-85.8) 53.6 (33.2-83.3)

Data are presented as No. (%) or median (interquartile range). eGFR = estimated glomerular filtration rate; LIPS = Lung Injury Prediction Score; SOFA = Sequential Organ Failure Assessment.